Name
Aktsiaselts Magnum Veterinaaria
Registry code
10007517
VAT number
EE100442270
Type
AS - Joint Stock Company
Status
Registered
Foundation date
16.01.1996 (28)
Financial year
01.05-30.04
Capital
223 051.00 €
Activity
46341 - Wholesale of alcoholic beverages 46181 - Agents specialised in the sale of other particular products 73121 - Media representation 46211 - Wholesale of grain, unmanufactured tobacco, seeds and animal feeds 46462 - Wholesale of medical appliances and surgical and orthopaedic instruments and devices 46461 - Wholesale of medicines and other pharmacy goods
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Aktsiaselts MAGNUM 12371718 | 100% - 223 051.00 EUR | - | - | Shareholder |
| Veronika Kuuskmann 22.05.1977 (47) | - | Board member | - | |
| Omanikukonto: MARGUS LINNAMÄE 05.01.1964 (60) | - | - | Indirect ownership | |
| Marika Pensa 14.08.1973 (51) | - | - | - | Board member |
| Veiko Vetto 13.06.1974 (50) | - | - | - | Board member |
| Mari Krass 06.05.1977 (47) | - | - | - | Chairman of the board |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Eesti Veterinaaria Kliinikum OÜ 12871585 | 100% - 93 182.00 EUR | - | - | |
| Pet City OÜ 12252155 | 100% - 2 500.00 EUR | - | - |
| 2019 30.10.2020 | 2020 30.10.2021 | 2021 30.10.2022 | 2022 30.10.2023 | |
|---|---|---|---|---|
| Total Revenue | 16 659 985 € | 19 365 672 € | 23 170 572 € | 26 216 192 € |
| Net profit (loss) for the period | 1 254 630 € | 1 199 882 € | 1 477 313 € | 1 398 261 € |
| Profit Margin | 8% | 6% | 6% | 5% |
| Current Assets | 9 146 708 € | 10 449 499 € | 11 645 759 € | 14 255 878 € |
| Fixed Assets | 9 158 124 € | 10 855 751 € | 14 698 748 € | 15 815 881 € |
| Total Assets | 18 304 832 € | 21 305 250 € | 26 344 507 € | 30 071 759 € |
| Current Liabilities | 3 260 890 € | 3 863 759 € | 3 555 703 € | 4 384 694 € |
| Non Current Liabilities | 9 546 988 € | 10 744 655 € | 14 614 655 € | 16 114 655 € |
| Total Liabilities | 12 807 878 € | 14 608 414 € | 18 170 358 € | 20 499 349 € |
| Share Capital | 223 051 € | 223 051 € | 223 051 € | 223 051 € |
| Equity | 5 496 954 € | 6 696 836 € | 8 174 149 € | 9 572 410 € |
| Employees | 26 | 33 | 36 | 37 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 10 064 835.53 € | 766 281.98 € | 181 136.71 € | 38 |
| 2023 Q4 | 10 426 312.49 € | 787 425.06 € | 182 765.09 € | 38 |
| 2023 Q3 | 9 652 567.44 € | 774 073.06 € | 181 363.95 € | 37 |
| 2023 Q2 | 10 698 168.29 € | 717 634.06 € | 173 747.99 € | 38 |
| 2023 Q1 | 10 118 497.4 € | 702 963.03 € | 158 519.09 € | 34 |
| 2022 Q4 | 9 695 387.34 € | 706 019.76 € | 156 183.92 € | 36 |
| 2022 Q3 | 8 841 166.6 € | 660 471.98 € | 148 973.37 € | 33 |
| 2022 Q2 | 9 356 575.8 € | 609 938.41 € | 137 368.48 € | 34 |
| 2022 Q1 | 8 661 537.87 € | 571 292.65 € | 132 610.55 € | 34 |
| 2021 Q4 | 9 376 035.97 € | 617 812.58 € | 130 334.05 € | 33 |
| 2021 Q3 | 8 118 259.45 € | 551 254.44 € | 127 398.67 € | 33 |
| 2021 Q2 | 9 989 674.09 € | 561 625.4 € | 109 491.06 € | 32 |
| 2021 Q1 | 6 562 488.87 € | 516 397.88 € | 104 379.25 € | 32 |
| 2020 Q4 | 7 629 958.53 € | 506 151.23 € | 110 876.58 € | 32 |
| 2020 Q3 | 6 708 455.44 € | 512 068.1 € | 109 109.31 € | 32 |
| 2020 Q2 | 7 015 066.97 € | 539 656.92 € | 102 936.74 € | 30 |
| 2020 Q1 | 6 244 158.55 € | 449 503.04 € | 90 430.47 € | 30 |
